<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2000
--------------
Check here if Amendment [ ]; Amendment Number:
---------------------------
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Perseus, L.L.C.
-------------------------------------
Address: The Army and Navy Club Building
-------------------------------------
1627 I Street, N.W., Suite 610
-------------------------------------
Washington, D.C. 20006
-------------------------------------
Form 13F File Number: 028-05587
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Rodd Macklin
-----------------------------------------------------
Title: Chief Financial Officer, Treasurer and Secretary
-----------------------------------------------------
Phone: (202) 452-0101
-----------------------------------------------------
Signature, Place, and Date of Signing:
/s/ RODD MACKLIN Washington, D.C. July 28, 2000
-------------------------- ------------------------------ --------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[ X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
<PAGE> 2
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
------------------------
Form 13F Information Table Entry Total: 29
------------------------
Form 13F Information Table Value Total: $17,741
------------------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
NONE
<PAGE> 3
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
------------------------- -------------- ---------- ---------- ---------------------- ------------ ---------- ----------------------
VOTING AUTHORITY
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER ----------------------
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE
------------------------- -------------- ---------- ---------- --------- ------- ---- ------------ ---------- -------- -------- ----
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Millennium
Pharmaceuticals,
Inc. Common 599902103 $455 3,500 SH SOLE 3,500
------------------------------------------------------------------------------------------------------------------------------------
NetObjects, Inc. Common 64114L102 $1,302 57,209 SH SOLE 57,209
------------------------------------------------------------------------------------------------------------------------------------
Texas
Biotechnology
Corporation Common 88221T104 $680 47,500 SH SOLE 47,500
------------------------------------------------------------------------------------------------------------------------------------
Quidel Corporation Common 74838J101 $490 70,000 SH SOLE 70,000
------------------------------------------------------------------------------------------------------------------------------------
NPS Pharmaceuticals,
Inc. Common 62936P103 $339 22,500 SH SOLE 22,500
------------------------------------------------------------------------------------------------------------------------------------
Aurora Biosciences
Corporation Common 051920106 $307 7,500 SH SOLE 7,500
------------------------------------------------------------------------------------------------------------------------------------
Alkermes, Inc. Common 01642T108 $1,249 13,500 SH SOLE 13,500
------------------------------------------------------------------------------------------------------------------------------------
CareInsite, Inc. Common 14170M106 $250 10,700 SH SOLE 10,700
------------------------------------------------------------------------------------------------------------------------------------
Neurocrine
Biosciences, Inc. Common 64125C109 $953 41,000 SH SOLE 41,000
------------------------------------------------------------------------------------------------------------------------------------
IDEC
Pharmaceuticals
Corporation Common 449370105 $1,081 11,000 SH SOLE 11,000
------------------------------------------------------------------------------------------------------------------------------------
Cephalon, Inc. Common 156708109 $825 22,000 SH SOLE 22,000
------------------------------------------------------------------------------------------------------------------------------------
Onyx Pharmaceuticals,
Inc. Common 683399109 $316 23,000 SH SOLE 23,000
------------------------------------------------------------------------------------------------------------------------------------
Magainin
Pharmaceuticals Inc. Common 559036108 $131 27,500 SH SOLE 27,500
------------------------------------------------------------------------------------------------------------------------------------
Johnson & Johnson Common 478160104 $246 3,500 SH SOLE 3,500
------------------------------------------------------------------------------------------------------------------------------------
Bristol-Myers Squibb
Company Common 110122108 $371 6,500 SH SOLE 6,500
------------------------------------------------------------------------------------------------------------------------------------
Pfizer Inc. Common 717081103 $823 22,500 SH SOLE 22,500
------------------------------------------------------------------------------------------------------------------------------------
Alza Corporation Common 022615108 $845 22,500 SH SOLE 22,500
------------------------------------------------------------------------------------------------------------------------------------
Advanced
Neuromodulation
Systems, Inc. Common 00757T101 $289 15,000 SH SOLE 15,000
------------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences, Inc. Common 375558103 $475 7,500 SH SOLE 7,500
------------------------------------------------------------------------------------------------------------------------------------
Amgen Inc. Common 031162100 $460 7,500 SH SOLE 7,500
------------------------------------------------------------------------------------------------------------------------------------
LJL Biosystems, Inc. Common 501873103 $456 25,000 SH SOLE 25,000
------------------------------------------------------------------------------------------------------------------------------------
Medimmune, Inc. Common 584699102 $348 2,000 SH SOLE 2,000
------------------------------------------------------------------------------------------------------------------------------------
American Home
Products Corporation Common 026609107 $538 10,000 SH SOLE 10,000
------------------------------------------------------------------------------------------------------------------------------------
Pharmacia Corporation Common 71713U102 $595 10,000 SH SOLE 10,000
------------------------------------------------------------------------------------------------------------------------------------
OSI Pharmaceuticals,
Inc. Common 671040103 $585 30,000 SH SOLE 30,000
------------------------------------------------------------------------------------------------------------------------------------
Emisphere Technologies,
Inc. Common 291345106 $856 16,500 SH SOLE 16,500
------------------------------------------------------------------------------------------------------------------------------------
Neose Technologies, Inc. Common 640522108 $885 27,500 SH SOLE 27,500
------------------------------------------------------------------------------------------------------------------------------------
Digene Corporation Common 253752109 $897 19,500 SH SOLE 19,500
------------------------------------------------------------------------------------------------------------------------------------
Insmed Incorporated Common 457669109 $694 100,000 SH SOLE 100,000
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
[Repeat as necessary]
